CXCR4 and neoplasm: Due to the critical role played by CXCR4 in HIV infection and tumor progression, there has been considerable interest in developing specific CXCR4 antagonists, a number of which are in the clinical development pipeline (Kuhne et al., 2013; www.clinicaltrials.gov).